Maha Hussain

OncoDaily

News Feed Opinion Career Insight Dialogues Blog Oncolibrary

Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me

Maha Hussain

Aug 10, 2024, 14:33 | Insight

Importance of early genetic testing for prostate cancer patients

Kenrick Ng, Consultant in Medical Oncology at Barts Health NHS Trust, shared on X about…

Aug 10, 2024, 12:17 | Insight

Emmanuel Antonarakis: Most compelling study suggesting that combined Abiraterone and Olaparib is better than sequential Abiraterone and Olaparib for 1st-line mCRPC

Emmanuel Antonarakis, Professor of Medicine at the University of Minnesota, shared a post on X…

Aug 5, 2024, 08:12 | Blog

Hedyeh Ebrahimi: Incredible experience attending the AACR-ASCO Methods in Clinical Cancer Workshop

Hedyeh Ebrahimi, Postdoctoral fellow at Genitourinary Cancer Research Team of City of Hope, shared a…

Jul 14, 2024, 06:27 | Blog

Georges Gebrael: Baseline bone pain associated with lower survival in mHSPC

Georges Gebrael, Research Fellow at Huntsman Cancer Institute and University of Utah, shared on X/Twitter:…

Jul 12, 2024, 16:05 | Insight

Piotr Wysocki: Bone Pain and Survival Among Patients With mHSPC

Piotr Wysocki recently posted on LinkedIn: "Bone pain is linked to worse overall survival (OS) in…

Jan 28, 2024, 18:54 | Societies

10 posts from ASCO GU 2024 by Yüksel Ürün

Yüksel Ürün, Professor of Medical Oncology at Ankara University, has recapped ASCO GU highlights on…

Jan 26, 2024, 13:52 | Opinion

Roberto Iacovelli: Interesting results of BRCA away study by Dr Maha Hussain at GU24

Roberto Iacovelli, Associate Professor of Medical Oncology at Catholic University, Comprehensive Cancer Center of Rome,…

All: 7 Posts: 1 - 100